The emerging role of serum/glucocorticoid-regulated kinases in cancer

Pau CastelHuman Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected] [email protected]

Maurizio ScaltritiHuman Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA;Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected] [email protected]

"The emerging role of serum/glucocorticoid-regulated kinases in cancer." Cell Cycle, 16(1), pp. 5–6

This article refers to:

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The emerging role of serum/glucocorticoid-regulated kinases in cancer

Information for

Open access

Opportunities

Help and information

The emerging role of serum/glucocorticoid-regulated kinases in cancer

Disclosure of potential conflicts of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature